For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Axikin Pharmaceuticals, Inc.

USPTO Granted Patents = 23

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 58

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Tai Wei Ly (18 out of 24 patents)

Garrett Thomas Potter (11 out of 12 patents)

Erik Dean Raaum (7 out of 8 patents)

4. Kevin Bacon (5 out of 12 patents)

5. Yingfu Li (4 out of 6 patents)

6. Keiko Fukushima (4 out of 5 patents)

7. Toshiya Moriwaki (4 out of 12 patents)

8. Klaus Urbahns (4 out of 24 patents)

9. Noriko Nunami (4 out of 5 patents)

10. Jared Andrew Forrester (3 out of 3 patents)

11. Timothy B Lowinger (2 out of 48 patents)

12. Naoki Tsuno (2 out of 29 patents)

13. Takashi Yoshino (2 out of 13 patents)

14. Kentaro Hashimoto (2 out of 2 patents)

15. Makiko Marumo (2 out of 3 patents)

23 patents: Sort by Forward Citations

1. 9730914 - 3,5-diaminopyrazole kinase inhibitors (2017-08-15),

2. 9637460 - Isotopically enriched arylsulfonamide CCR3 antagonists (2017-05-02),

3. 9546163 - 3,5-diaminopyrazole kinase inhibitors (2017-01-17),

4. 9540351 - Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors (2017-01-10),

5. 9382237 - 3,5-diaminopyrazole kinase inhibitors (2016-07-05),

6. 9365556 - 3,5-diaminopyrazole kinase inhibitors (2016-06-14),

7. 9346792 - 3,5-diaminopyrazole kinase inhibitors (2016-05-24),

8. 9206186 - 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders (2015-12-08),

9. 9187425 - 2,5-disubstituted arylsulfonamide CCR3 antagonists (2015-11-17),

10. 9156799 - Isotopically enriched arylsulfonamide CCR3 antagonists (2015-10-13),

11. 8999995 - Isotopically enriched arylsulfonamide CCR3 antagonists (2015-04-07),

12. 8916555 - 3,5-diaminopyrazole kinase inhibitors (2014-12-23),

13. 8741894 - Arylsulfonamide CCR3 antagonists (2014-06-03),

14. 8669247 - 2,5-disubstituted arylsulfonamide CCR3 antagonists (2014-03-11),

15. 8658642 - Arylsulfonamide CCR3 antagonists (2014-02-25),

Axikin Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies to address unmet medical needs. With a focus on immunology, we aim to deliver transformative treatments for patients suffering from debilitating diseases. Through rigorous scientific research and strategic collaborations, our goal is to improve the lives of patients and provide hope for those with limited treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#247 in San Diego, CA

#3,302 in California

#13,951 in US

#26,826 in the World

San Diego, CA, United States of America

Axikin Pharmaceuticals, Inc.

Forward Citations = 58

28 inventors:

Tai Wei Ly (18 out of 24 patents)

Garrett Thomas Potter (11 out of 12 patents)

Erik Dean Raaum (7 out of 8 patents)

4. Kevin Bacon (5 out of 12 patents)

5. Yingfu Li (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…